Stock Track | Tempus AI Plunges Over 15% in Pre-Market on Disappointing Q4 Earnings and Wider Annual Losses

Stock Track
02-25

Tempus AI (TEM) stock plummeted more than 15% in pre-market trading on Tuesday, following the company's release of disappointing fourth-quarter and full-year 2024 financial results. Despite solid revenue growth, the precision medicine technology firm's wider-than-expected losses overshadowed its positive outlook for 2025.

For the fourth quarter, Tempus AI reported revenue of $200.7 million, up 35.8% year-over-year, but missed analyst estimates of $203.1 million. The company's adjusted net loss widened to $0.18 per share, missing analyst expectations of a $0.16 loss.

The company's full-year 2024 performance was even more concerning, with a net loss of $705.8 million, significantly wider than the $214.1 million loss in 2023. This was largely due to $547.7 million in stock-based compensation expenses, which overshadowed the 30.4% increase in annual revenue to $693.4 million.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10